Scientists from China have developed a new broad-spectrum mRNA vaccine that could provide long-term protection against the most lethal family of Ebola viruses, including the Bundibugyo strain behind ...

AMD CEO Lisa Su arrived in Taiwan on May 20, 2026, on a private jet and largely followed the same itinerary as her April 2025 visit, including a meeting with TSMC, a technology forum and dinner with ...

Ingelheim, Germany and Ridgefield, Conn., US – At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Boehringer Ingelheim will present new data from across its robust oncology ...

RIDGEFIELD, Conn. and INGELHEIM, Germany, May 21, 2026 /PRNewswire/ -- At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Boehringer Ingelheim will present new data from across ...

Early data to be presented highlights the potential of HERNEXEOS in other HER2-driven cancers, including metastatic colorectal cancer (mCRC), metastatic gastric, gastroesophageal junction, or ...

New patient-reported outcomes data shows improved function and reduced symptom burden with HERNEXEOS® (zongertinib tablets) as an initial treatment option in HER2 (ERBB2)-mutant advanced non-small ...

Foralumab nasal spray shows promise for nonactive secondary progressive multiple sclerosis. It slows disability progression and significantly eases fatigue in patients. This well-tolerated treatment ...

Brian Morrissey, the department’s general counsel, stepped down hours after the Trump administration announced the $1.8 billion fund. By Andrew Duehren Reporting from Washington The top lawyer at the ...

LIB820 is a CAR-M cell therapy for autoimmune diseases like multiple sclerosis (MS). It eliminates disease-driving B-cells by engineering monocytes/macrophages. Preclinical data supports its promise; ...

Hundreds of packages across npm and PyPI have been compromised in a new Shai-Hulud supply-chain campaign delivering credential-stealing malware targeting developers. The attacker hijacked valid OpenID ...